Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: Key tools for studying and treating estrogen-dependent diseases (Q37823705)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 21, 2010

Language	Label	Description	Also known as
English	Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: Key tools for studying and treating estrogen-dependent diseases	scientific article published on December 21, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: key tools for studying and treating estrogen-dependent diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: Key tools for studying and treating estrogen-dependent diseases (English)

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

1 reference

based on heuristic

inferred from title

author name string

Donald Poirier

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0960076010003912?httpAccept=text/xml

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

https://api.elsevier.com/content/article/PII:S0960076010003912?httpAccept=text/plain

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

The Journal of Steroid Biochemistry and Molecular Biology

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

125

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

83-94

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones

1

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Molecular endocrinology of hydroxysteroid dehydrogenases

2

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Mechanism Based Inhibition of Hydroxysteroid Dehydrogenases

3

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues

4

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology

5

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

The intracrine sex steroid biosynthesis pathways

6

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Integrated view on 17beta-hydroxysteroid dehydrogenases

7

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Multifunctionality of human 17beta-hydroxysteroid dehydrogenases

8

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Structure and function of human 17beta-hydroxysteroid dehydrogenases

9

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase

10

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

The interconversion of estrone and estradiol by human tissue slices

11

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review

12

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Advances in development of inhibitors of 17beta hydroxysteroid dehydrogenases

13

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

17beta-hydroxysteroid dehydrogenases in human breast cancer

14

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Perspectives in understanding the role of human 17beta-hydroxysteroid dehydrogenases in health and disease.

15

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

16

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis

17

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

The selective estrogen enzyme modulators in breast cancer: a review

19

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Inhibitors of 17 beta-hydroxysteroid dehydrogenases

20

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Control of cell proliferation by steroids: the role of 17HSDs

21

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

17 beta-hydroxysteroid dehydrogenases--their role in pathophysiology.

22

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Is dehydroepiandrosterone a hormone?

23

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone

24

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers

25

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site

27

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Full oestrogenic activity of C19-delta 5 adrenal steroids in rat pituitary lactotrophs and somatotrophs

30

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Synthesis and biological activities of thioether derivatives related to the antiestrogens tamoxifen and ICI 164384.

31

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

A 6beta-(thiaheptanamide) derivative of estradiol as inhibitor of 17beta-hydroxysteroid dehydrogenase type 1

32

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Inhibitors of type 1 17beta-hydroxysteroid dehydrogenase with reduced estrogenic activity: modifications of the positions 3 and 6 of estradiol

33

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

C6-(N,N-butyl-methyl-heptanamide) derivatives of estrone and estradiol as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: Chemical synthesis and biological evaluation

34

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Characteristics of human types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition

37

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Intracellular regulation of 17 beta-hydroxysteroid dehydrogenase type 2 catalytic activity in A431 cells

38

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Synthesis of 16-(bromoalkyl)-estradiols having inhibitory effect on human placental estradiol 17β-hydroxysteroid dehydrogenase (17-β-HSD type 1)

39

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Overview of a rational approach to design type I 17beta-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological evaluation

40

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

N-butyl, N-methyl, 11-[3',17' beta-(dihydroxy)-1',3',5'(10')-estratrien-16' alpha-yl]-9(R/S)-bromo undecanamide: synthesis and 17 beta-HSD inhibiting, estrogenic and antiestrogenic activities

42

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Synthesis and evaluation of estradiol derivatives with 16 alpha-(bromoalkylamide), 16 alpha-(bromoalkyl) or 16 alpha-(bromoalkynyl) side chain as inhibitors of 17 beta-hydroxysteroid dehydrogenase type 1 without estrogenic activity

43

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Fast kinetic study of yeast phenylalanyl-tRNA synthetase: an efficient discrimination between tyrosine and phenylalanine at the level of the aminoacyladenylate-enzyme complex

46

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Crystallization and Preliminary X-ray Diffraction Analysis of the Complex of Human Placental 17β-Hydroxysteroid Dehydrogenase with NADP+

47

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Structure of human estrogenic 17β-hydroxysteroid dehydrogenase at 2.20 å resolution

48

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Crystal structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase complexed with 17 beta-estradiol

49

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Synthesis of a First Estradiol-Adenosine Hybrid Compound

50

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Estradiol-adenosine hybrid compounds designed to inhibit type 1 17beta-hydroxysteroid dehydrogenase

51

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

A concerted, rational design of type 1 17beta-hydroxysteroid dehydrogenase inhibitors: estradiol-adenosine hybrids with high affinity

52

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Improved synthesis of EM-1745, preparation of its C17-ketone analogue and comparison of their inhibitory potency on 17beta-hydroxysteroid dehydrogenase type 1.

53

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Design and synthesis of bisubstrate inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: overview and perspectives

54

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Synthesis of simplified hybrid inhibitors of type 1 17beta-hydroxysteroid dehydrogenase via cross-metathesis and sonogashira coupling Reactions

55

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Chemical synthesis of 16beta-propylaminoacyl derivatives of estradiol and their inhibitory potency on type 1 17beta-hydroxysteroid dehydrogenase and binding affinity on steroid receptors.

57

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Solid-phase synthesis of phenolic steroids: from optimization studies to a convenient procedure for combinatorial synthesis of biologically relevant estradiol derivatives

58

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Solid-phase synthesis of hydroxysteroid derivatives using the diethylsilyloxy linker

59

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

The sulfamate functional group as a new anchor for solid-phase organic synthesis

60

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Recent developments of steroid sulfatase inhibitors as anti-cancer agents.

61

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Estrone sulfatase and its inhibitors

62

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Therapeutic applications of sulfamates

63

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Solid-phase organic synthesis (SPOS) of modulators of estrogenic and androgenic action

64

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

A multidetachable sulfamate linker successfully used in a solid-phase strategy to generate libraries of sulfamate and phenol derivatives

65

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Synthesis of aryl sulfamate and phenol small peptide derivatives using a multidetachable sulfamate linker strategy

67

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Synthesis of libraries of 16beta-aminopropyl estradiol derivatives for targeting two key steroidogenic enzymes

68

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Preparation of 6beta-estradiol derivative libraries as bisubstrate inhibitors of 7beta-hydroxysteroid dehydrogenase type using the multidetachable sulfamate linker.

69

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Estrone and estradiol C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase

70

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

New inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

71

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Novel compounds inhibit estrogen formation and action

72

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Focused libraries of 16-substituted estrone derivatives and modified e-ring steroids: inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

73

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone

74

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Binary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapy

75

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Human Estrogenic 17β-Hydroxysteroid Dehydrogenase: Predominance of Estrone Reduction and Its Induction by NADPH

76

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Determination of cDNA, gene structure and chromosomal localization of the novel human 17beta-hydroxysteroid dehydrogenase type 7(1)

77

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

17beta-hydroxysteroid dehydrogenase type 7--an ancient 3-ketosteroid reductase of cholesterogenesis.

78

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7.

79

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study

80

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Effects of 3-beta-diol, an androgen metabolite with intrinsic estrogen-like effects, in modulating the aquaporin-9 expression in the rat efferent ductules

81

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Closing the gap: identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis

82

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Promoter analyses of human and mouse 17beta-hydroxysteroid dehydrogenase type 7.

83

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Transcriptional regulation of human and murine 17beta-hydroxysteroid dehydrogenase type-7 confers its participation in cholesterol biosynthesis

84

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone

86

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities

87

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors

89

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Steroid-converting enzymes in human ovarian carcinomas

90

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Specific estradiol biosynthetic pathway in choriocarcinoma (JEG-3) cell line

91

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).

92

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells

93

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production

94

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent d

95

1 reference

10.1016/J.JSBMB.2010.12.007

https://api.crossref.org/works/10.1016/J.JSBMB.2010.12.007

20 November 2024

Identifiers

10.1016/J.JSBMB.2010.12.007

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37823705&oldid=2277613588"